Cargando…

Plasma Adenosine Deaminase (ADA)-1 and -2 Demonstrate Robust Ontogeny Across the First Four Months of Human Life

BACKGROUND: Human adenosine deaminases (ADAs) modulate the immune response: ADA1 via metabolizing adenosine, a purine metabolite that inhibits pro-inflammatory and Th1 cytokine production, and the multi-functional ADA2, by enhancing T-cell proliferation and monocyte differentiation. Newborns are rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Odumade, Oludare A., Plotkin, Alec L., Pak, Jensen, Idoko, Olubukola T., Pettengill, Matthew A., Kollmann, Tobias R., Ozonoff, Al, Kampmann, Beate, Levy, Ofer, Smolen, Kinga K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190399/ https://www.ncbi.nlm.nih.gov/pubmed/34122398 http://dx.doi.org/10.3389/fimmu.2021.578700

Ejemplares similares

Ontogeny of plasma cytokine and chemokine concentrations across the first week of human life
por: Smolen, Kinga K., et al.
Publicado: (2021)

Soluble Ecto-5′-nucleotidase (5′-NT), Alkaline Phosphatase, and Adenosine Deaminase (ADA1) Activities in Neonatal Blood Favor Elevated Extracellular Adenosine
por: Pettengill, Matthew, et al.
Publicado: (2013)

Adenosine Deaminase (ADA) Level in Tubercular Pleural Effusion
por: Verma, S.K., et al.
Publicado: (2008)

Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis
por: Gao, Zhao-wei, et al.
Publicado: (2022)

Inhibition of adenosine deaminase (ADA)-mediated metabolism of cordycepin by natural substances
por: Li, Gen, et al.
Publicado: (2015)

Diagnostic Value of Serum Adenosine Deaminase (ADA) Level for Pulmonary Tuberculosis
por: Salmanzadeh, Shokrollah, et al.
Publicado: (2015)

Precision Vaccines: Lessons Learned From the Coronavirus Pandemic( )
por: Angelidou, Asimenia, et al.
Publicado: (2022)

Polymorphisme de l'adénosine déaminase (ada) dans l'espèce bovine
por: Ansay, M, et al.
Publicado: (1972)

Novel Adenosine Deaminase 2 (ADA2) Mutations Associated With Hematological Manifestations
por: Albalawi, Reem, et al.
Publicado: (2021)

Review of Treatment for Adenosine Deaminase Deficiency (ADA) Severe Combined Immunodeficiency (SCID)
por: Secord, Elizabeth, et al.
Publicado: (2022)

Atypical presentation of adenosine deaminase 2 deficiency with bi‐allelic ADA2 mutation
por: Al‐shaikh, Reem, et al.
Publicado: (2022)

PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID
por: Dorsey, Morna J., et al.
Publicado: (2023)

Vaccine Interactions With the Infant Microbiome: Do They Define Health and Disease?
por: Ruck, Candice E., et al.
Publicado: (2020)

A single birth dose of Hepatitis B vaccine induces polyfunctional CD4(+) T helper cells
por: Strandmark, Julia, et al.
Publicado: (2022)

Relation of serum adenosine deaminase (ADA) levels with sputum smear conversion in patients with pulmonary tuberculosis
por: Okutan, Oguzhan, et al.
Publicado: (2006)

Correction to: PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID
por: Dorsey, Morna J., et al.
Publicado: (2023)

Use of adenosine deaminase (ADA) to diagnose suspected peritoneal tuberculosis in Rwanda: a cross-sectional study
por: Ntwari, Jules, et al.
Publicado: (2020)

Novel ADA2 Compound Heterozygous Mutations Resulting in Deficiency of Adenosine Deaminase 2 in a Pair of Siblings
por: Guo, Li, et al.
Publicado: (2021)

Lentiviral Mediated ADA2 Gene Transfer Corrects the Defects Associated With Deficiency of Adenosine Deaminase Type 2
por: Hong, Ying, et al.
Publicado: (2022)

ELISA based assays to measure adenosine deaminases concentration in serum and saliva for the diagnosis of ADA2 deficiency and cancer
por: Luo, Wenwen, et al.
Publicado: (2022)

Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea
por: Idoko, Olubukola T., et al.
Publicado: (2020)

Corrigendum: Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea
por: Idoko, Olubukola T., et al.
Publicado: (2020)

Levels of adenosine deaminase in some experimental animal tumours and the possible therapeutic effect of the ADA inhibitor 2-deoxy-coformycin.
por: Hall, J. G., et al.
Publicado: (1979)

Evaluation of the adenosine deaminase (ADA) G22A gene polymorphism with recurrent spontaneous abortion among Egyptian patients
por: Farhan, Hanan Mohamed, et al.
Publicado: (2017)

Antimicrobial Proteins and Peptides in Early Life: Ontogeny and Translational Opportunities
por: Battersby, Anna J., et al.
Publicado: (2016)

Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity
por: Lee, Jae-Geun, et al.
Publicado: (2011)

The ADA*2 allele of the adenosine deaminase gene (20q13.11) and recurrent spontaneous abortions: an age-dependent association
por: Nunes, Daniela Prudente Teixeira, et al.
Publicado: (2011)

Utility of adenosine deaminase (ADA), PCR & thoracoscopy in differentiating tuberculous & non-tuberculous pleural effusion complicating chronic kidney disease
por: Kumar, Sravan, et al.
Publicado: (2015)

Evaluation of adenosine deaminase (ADA) isoenzymes activity and tumor necrosis factor-α (TNFα) concentration in chronic heart failure
por: Khodadadi, IrajI, et al.
Publicado: (2014)

Diagnostic Accuracy of Cerebrospinal Fluid (CSF) Adenosine Deaminase (ADA) for Tuberculous Meningitis (TBM) in Adults: A Systematic Review and Meta-Analysis
por: Prasad, Manoj Kumar, et al.
Publicado: (2023)

Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer
por: Zhulai, Galina, et al.
Publicado: (2022)

Bacille Calmette–Guérin vaccine reprograms human neonatal lipid metabolism in vivo and in vitro
por: Diray-Arce, Joann, et al.
Publicado: (2022)

Adenosine deaminase activity in leukaemia.
por: Smyth, J. F., et al.
Publicado: (1975)

OR13-002 Recessive mutations in CECR1, encoding adenosine deaminase 2 (ADA2), cause systemic and cutaneous polyarteritis nodosa (PAN)
por: Levy-Lahad, E, et al.
Publicado: (2013)

Discrimination of Exudative Pleural Effusions Based on Pleural Adenosine Deaminase (ADA)-C-Reactive Protein (CRP) Levels, and Their Combination: An Observational Prospective Study
por: Perlepe, Garifallia, et al.
Publicado: (2021)

OR13-001 Loss-of-function mutations in CECR1, encoding adenosine deaminase 2 (ADA2), cause recurrent fevers and early onset strokes
por: Zhou, Q, et al.
Publicado: (2013)

Neutropenia in patients with adenosine deaminase deficiency
por: Kim, Vy HD, et al.
Publicado: (2014)

Adenosine deaminase in exudative pleural effusions
por: Wiwanitkit, Somsri, et al.
Publicado: (2014)

Adenosine deaminase deficiency: a review
por: Flinn, Aisling M., et al.
Publicado: (2018)

Urogenital Abnormalities in Adenosine Deaminase Deficiency
por: Pajno, Roberta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_snmq5lkne0q50duf6doqcgpv4g